Civic Intelligence

Sagerstrong Foundation Inc

990 • Fiscal year 2016 • EIN 81-2388305

Jan 01, 2016 to Dec 31, 2016

Atlanta, GA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Liabilities / Revenue

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Net Margin

95th percentile

68%

Higher net margin than 95% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2016

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2016

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2016

Assets

$139,393

No earlier filing loaded for comparison.

Net Assets

$139,393

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$204,245

No earlier filing loaded for comparison.

Expenses

$64,852

No earlier filing loaded for comparison.

Net Income

$139,393

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0-$200KAssets 2016: $139,393Liabilities 2016: $0Net Assets 2016: $139,3932016Assets 2017: $650,508Liabilities 2017: $0Net Assets 2017: $650,5082017Assets 2018: $592,571Liabilities 2018: $0Net Assets 2018: $592,5712018Assets 2019: $335,473Liabilities 2019: $0Net Assets 2019: $335,4732019Assets 2020: $376,020Liabilities 2020: $130,094Net Assets 2020: $245,9262020Assets 2021: $324,505Liabilities 2021: $129,376Net Assets 2021: $195,1292021Assets 2022: $236,969Liabilities 2022: $155,623Net Assets 2022: $81,3462022Assets 2023: $399,799Liabilities 2023: $378,597Net Assets 2023: $21,2022023Assets 2024: $394,968Liabilities 2024: $399,186Net Assets 2024: -$4,2182024

Highlighted filing

2016

Assets$139,393
Liabilities$0
Net Assets$139,393

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2016: $204,245Expenses 2016: $64,852Net Income 2016: $139,3932016Revenue 2017: $930,804Expenses 2017: $419,689Net Income 2017: $511,1152017Revenue 2018: $146,669Expenses 2018: $130,990Net Income 2018: $15,6792018Revenue 2019: $25,661Expenses 2019: $282,759Net Income 2019: -$257,0982019Revenue 2020: $30,717Expenses 2020: $120,264Net Income 2020: -$89,5472020Revenue 2021: $108,265Expenses 2021: $159,062Net Income 2021: -$50,7972021Revenue 2022: $121,993Expenses 2022: $235,776Net Income 2022: -$113,7832022Revenue 2023: $178,886Expenses 2023: $313,863Net Income 2023: -$134,9772023Revenue 2024: $58,457Expenses 2024: $83,877Net Income 2024: -$25,4202024

Highlighted filing

2016

Revenue$204,245
Expenses$64,852
Net Income$139,393
Filing Detail Status

This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview

Mission

The support of clinical trials and cancer research for leukemia and other blood cancers.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings